Literature DB >> 9154810

Regulated expression and RNA processing of transcripts from the Srp20 splicing factor gene during the cell cycle.

H Jumaa1, J L Guénet, P J Nielsen.   

Abstract

Eukaryotic splicing factors belonging to the SR family are essential splicing factors consisting of an N-terminal RNA-binding region and a C-terminal RS domain. They are believed to be involved in alternative splicing of numerous transcripts because their expression levels can influence splice site selection. We have characterized the structure and transcriptional regulation of the gene for the smallest member of the SR family, SRp20 (previously called X16). The mouse gene encoding SRp20, termed Srp20, consists of one alternative exon and six constitutive exons and was mapped to a 2-centimorgan interval on chromosome 17. When cells are transfected with SRp20 genomic DNA, both standard and alternatively spliced transcripts and corresponding proteins are produced. Interestingly, in starved (G0) cells, the amount of SRp20 mRNA containing the alternative exon is large, whereas the amount of the standard SRp20 mRNA without the alternative exon is small. When starved cells are stimulated with serum, the alternative form is lost and the standard form is induced. These results suggest that splicing could be regulated during the cell cycle and that this could be, at least in part, due to regulated expression of SR proteins. Consistent with this, experiments with synchronized cells showed an induction of SRp20 transcripts in late G1 or early S. We have also characterized the promoter of SRp20. It lies within a GC-rich CpG island and contains two consensus binding sites for E2F, a transcription factor thought to be involved in regulating the cell cycle. These motifs may be functional since reporter constructs with the SRp20 promoter can be stimulated by cotransfection with E2F expression plasmids.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9154810      PMCID: PMC232164          DOI: 10.1128/MCB.17.6.3116

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  56 in total

1.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

2.  SR alpha promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat.

Authors:  Y Takebe; M Seiki; J Fujisawa; P Hoy; K Yokota; K Arai; M Yoshida; N Arai
Journal:  Mol Cell Biol       Date:  1988-01       Impact factor: 4.272

3.  RNA recognition: towards identifying determinants of specificity.

Authors:  D J Kenan; C C Query; J D Keene
Journal:  Trends Biochem Sci       Date:  1991-06       Impact factor: 13.807

Review 4.  CpG-rich islands and the function of DNA methylation.

Authors:  A P Bird
Journal:  Nature       Date:  1986 May 15-21       Impact factor: 49.962

5.  Regulation of sexual differentiation in D. melanogaster via alternative splicing of RNA from the transformer gene.

Authors:  R T Boggs; P Gregor; S Idriss; J M Belote; M McKeown
Journal:  Cell       Date:  1987-08-28       Impact factor: 41.582

6.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

7.  Establishment and characterization of BALB/c lymphoma lines with B cell properties.

Authors:  K J Kim; C Kanellopoulos-Langevin; R M Merwin; D H Sachs; R Asofsky
Journal:  J Immunol       Date:  1979-02       Impact factor: 5.422

8.  Targeted disruption of an essential vertebrate gene: ASF/SF2 is required for cell viability.

Authors:  J Wang; Y Takagaki; J L Manley
Journal:  Genes Dev       Date:  1996-10-15       Impact factor: 11.361

9.  Production of large numbers of mitotic mammalian cells by use of the reversible microtubule inhibitor nocodazole. Nocodazole accumulated mitotic cells.

Authors:  G W Zieve; D Turnbull; J M Mullins; J R McIntosh
Journal:  Exp Cell Res       Date:  1980-04       Impact factor: 3.905

10.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

View more
  29 in total

1.  Role of SFRS13A in low-density lipoprotein receptor splicing.

Authors:  I-Fang Ling; Steven Estus
Journal:  Hum Mutat       Date:  2010-06       Impact factor: 4.878

2.  Downregulation of splicing factor SRSF3 induces p53β, an alternatively spliced isoform of p53 that promotes cellular senescence.

Authors:  Y Tang; I Horikawa; M Ajiro; A I Robles; K Fujita; A M Mondal; J K Stauffer; Z-M Zheng; C C Harris
Journal:  Oncogene       Date:  2012-07-09       Impact factor: 9.867

3.  Regulation of alternative polyadenylation by U1 snRNPs and SRp20.

Authors:  H Lou; K M Neugebauer; R F Gagel; S M Berget
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

4.  Characterization of SRp46, a novel human SR splicing factor encoded by a PR264/SC35 retropseudogene.

Authors:  J Soret; R Gattoni; C Guyon; A Sureau; M Popielarz; E Le Rouzic; S Dumon; F Apiou; B Dutrillaux; H Voss; W Ansorge; J Stévenin; B Perbal
Journal:  Mol Cell Biol       Date:  1998-08       Impact factor: 4.272

5.  Cyclin E associates with components of the pre-mRNA splicing machinery in mammalian cells.

Authors:  W Seghezzi; K Chua; F Shanahan; O Gozani; R Reed; E Lees
Journal:  Mol Cell Biol       Date:  1998-08       Impact factor: 4.272

6.  Alternative splicing of the fibronectin EIIIB exon depends on specific TGCATG repeats.

Authors:  L P Lim; P A Sharp
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

7.  Changes in ovarian protein expression during primordial follicle formation in the hamster.

Authors:  Anindit Mukherjee; Nichole Reisdorph; Chttibabu Guda; Sanjit Pandey; Shyamal K Roy
Journal:  Mol Cell Endocrinol       Date:  2011-07-28       Impact factor: 4.102

8.  The splicing factor SRp20 modifies splicing of its own mRNA and ASF/SF2 antagonizes this regulation.

Authors:  H Jumaa; P J Nielsen
Journal:  EMBO J       Date:  1997-08-15       Impact factor: 11.598

9.  Construction of a high-resolution 2.5-Mb transcript map of the human 6p21.2-6p21.3 region immediately centromeric of the major histocompatibility complex.

Authors:  N Tripodis; S Palmer; S Phillips; S Milne; S Beck; J Ragoussis
Journal:  Genome Res       Date:  2000-04       Impact factor: 9.043

10.  Regulation of alternative splicing by SRrp86 and its interacting proteins.

Authors:  Jun Li; Ian C Hawkins; Christopher D Harvey; Jennifer L Jennings; Andrew J Link; James G Patton
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.